http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0345671-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
filingDate 1989-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0345671-A3
titleOfInvention Cephem compounds and processes for preparation thereof
abstract A compound of the formula : <CHEM> wherein R<1> is amino or a protected amino group, Z is N or CH, R<2> is an organic group, and R is a group of the formula : <CHEM> (in which R<3> and R<4> are each lower alkyl, or R<3> and R<4> are linked together to form C3-C6 alkylene, A is lower alkylene, and R<5> is hydroxy or a protected hydroxy group) or a group of the formula : <CHEM> (in which R<6> is lower alkyl, R<7> and R<8> are each hydroxy or a protected hydroxy group, and Y is N or CH), and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient. The invention relates also to intermediates of the formula <CHEM> and their preparation. o
priorityDate 1988-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0192176-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0267733-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20836467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18635708

Total number of triples: 25.